|
Delayed
Nasdaq
16:01:31 11/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 6.815 USD | +1.11% |
|
+5.36% | -11.14% |
| 16/06/25 | Crescent Biopharma Completes Merger With GlycoMimetics | MT |
| 30/10/23 | Catalyst Biosciences, Inc.(NasdaqCM:CBIO) dropped from NASDAQ Composite Index | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CATALYST BIOSCIENCES | - | +1.11% | +5.36% | -11.14% | - | -90.46% | 19.42M |  | | |
- Stock Market
- Stocks
- CBIO Stock
- Charts Catalyst Biosciences
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
